chr7-130308381-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_016352.4(CPA4):c.777G>A(p.Trp259*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00361 in 1,614,060 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 16 hom. )
Consequence
CPA4
NM_016352.4 stop_gained
NM_016352.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 7.14
Genes affected
CPA4 (HGNC:15740): (carboxypeptidase A4) This gene is a member of the carboxypeptidase A/B subfamily, and it is located in a cluster with three other family members on chromosome 7. Carboxypeptidases are zinc-containing exopeptidases that catalyze the release of carboxy-terminal amino acids, and are synthesized as zymogens that are activated by proteolytic cleavage. This gene could be involved in the histone hyperacetylation pathway. It is imprinted and may be a strong candidate gene for prostate cancer aggressiveness. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 7-130308381-G-A is Benign according to our data. Variant chr7-130308381-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 776598.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr7-130308381-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA4 | NM_016352.4 | c.777G>A | p.Trp259* | stop_gained | 8/11 | ENST00000222482.10 | NP_057436.2 | |
CPA4 | NM_001163446.2 | c.678G>A | p.Trp226* | stop_gained | 7/10 | NP_001156918.1 | ||
CPA4 | XM_047420438.1 | c.465G>A | p.Trp155* | stop_gained | 8/11 | XP_047276394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA4 | ENST00000222482.10 | c.777G>A | p.Trp259* | stop_gained | 8/11 | 1 | NM_016352.4 | ENSP00000222482.4 | ||
CPA4 | ENST00000445470.6 | c.678G>A | p.Trp226* | stop_gained | 7/10 | 2 | ENSP00000412947.2 | |||
CPA4 | ENST00000493259.5 | c.465G>A | p.Trp155* | stop_gained | 6/9 | 2 | ENSP00000419660.1 | |||
CPA4 | ENST00000488025.1 | n.250G>A | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00248 AC: 377AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
377
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00234 AC: 588AN: 251442Hom.: 0 AF XY: 0.00254 AC XY: 345AN XY: 135896
GnomAD3 exomes
AF:
AC:
588
AN:
251442
Hom.:
AF XY:
AC XY:
345
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00373 AC: 5453AN: 1461758Hom.: 16 Cov.: 30 AF XY: 0.00365 AC XY: 2652AN XY: 727190
GnomAD4 exome
AF:
AC:
5453
AN:
1461758
Hom.:
Cov.:
30
AF XY:
AC XY:
2652
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00248 AC: 377AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74470
GnomAD4 genome
AF:
AC:
377
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
20
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
34
ExAC
AF:
AC:
285
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 24, 2017 | - - |
CPA4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
0.27, 0.27, 0.24
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at